Related Experiment Video
Updated: Jul 17, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Pheochromocytoma triggered by coronavirus disease 2019: a case report
Hoda Naghshineh1, Amirhossein Hasanpour2, Naghmeh Ziaei3
1Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Ganjafroz Street, Babol, I. R. of Iran.
Background:
Coronavirus disease 2019 is an infectious disease with many presentations, and many of its effects on the human body are still unknown. Pheochromocytoma is a neuroendocrine tumor that may occur sporadically or be a manifestation of a hereditary disease line multiple endocrine neoplasia type 2.
Case Presentation:
In this study, we report a case of an Iranian patient infected with coronavirus disease 2019, causing unusual presentations of pheochromocytoma, including myocarditis and cerebrovascular involvement.
Conclusions:
We discovered a case of pheochromocytoma as an unusual presentation of COVID-19. In further investigations we also discovered thyroid medullary carcinoma and at the end MEN 2 syndrome was diagnosed. After proper treatment many symptoms were eliminated.
Insights
This study presents a rare case where coronavirus disease 2019 (COVID-19) unusually manifested as pheochromocytoma, leading to myocarditis and cerebrovascular issues. Further investigation revealed thyroid medullary carcinoma and Multiple Endocrine Neoplasia type 2 syndrome in the patient.
Area of Science:
- Endocrinology
- Infectious Diseases
- Oncology
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse and not fully understood effects on the human body.
- Pheochromocytoma, a neuroendocrine tumor, can arise sporadically or as part of hereditary syndromes like Multiple Endocrine Neoplasia type 2 (MEN 2).
Observation:
- A case report details an Iranian patient with COVID-19 exhibiting unusual pheochromocytoma manifestations.
- These unusual presentations included myocarditis and cerebrovascular involvement.
Findings:
- The study identified pheochromocytoma as an atypical manifestation of COVID-19.
- Further diagnostic workup confirmed co-existing thyroid medullary carcinoma and MEN 2 syndrome.
- Successful treatment led to the resolution of many of the patient's symptoms.
Implications:
- This case highlights the complex interplay between COVID-19 infection and endocrine disorders.
- It underscores the importance of considering unusual presentations in patients with COVID-19.
- The findings suggest a potential link between severe viral infections and the unmasking or development of hereditary endocrine syndromes.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
03:42High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
Published on: May 18, 2022
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cytomegalovirus Disease
Coronavirus
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology